# Innovex International, Inc. (INVX) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from Innovex International, Inc.'s 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/INVX/mda/fy2025/): filed 2026-02-24; accession 0001193125-26-067228 (https://www.sec.gov/Archives/edgar/data/1042893/000119312526067228/invx-20251231.htm); latest 10-K
- [FY 2024 MD&A](/company/INVX/mda/fy2024/): filed 2025-03-03; accession 0000950170-25-031003 (https://www.sec.gov/Archives/edgar/data/1042893/000095017025031003/invx-20241231.htm)
- [FY 2023 MD&A](/company/INVX/mda/fy2023/): filed 2024-02-27; accession 0000950170-24-020662 (https://www.sec.gov/Archives/edgar/data/1042893/000095017024020662/drq-20231231.htm)
- [FY 2022 MD&A](/company/INVX/mda/fy2022/): filed 2023-03-01; accession 0000950170-23-005506 (https://www.sec.gov/Archives/edgar/data/1042893/000095017023005506/drq-20221231.htm)
- [FY 2021 MD&A](/company/INVX/mda/fy2021/): filed 2022-02-23; accession 0000950170-22-001780 (https://www.sec.gov/Archives/edgar/data/1042893/000095017022001780/drq-20211231.htm)

Back to /company/INVX/